Novartis has announced that its CIBA Vision division has reached a global settlement with Johnson & Johnson Vision Care to license CIBA's 'Nicholson' patents for silicone hydrogel contact lens technology.
The settlement ends ongoing litigation in the US as well as several European countries (News 05.11.10).
Novartis said that the agreement covered Johnson & Johnson's full portfolio of silicone hydrogel contact lenses, including Acuvue Oasys, Acuvue Advance and 1-Day Acuvue TruEye.
It allows Johnson & Johnson to continue to manufacture, market and sell its silicone hydrogel contact lenses on a worldwide basis under a licence from CIBA, including markets under court-ordered injunction.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here